Spots Global Cancer Trial Database for lung diseases
Every month we try and update this database with for lung diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT04222972 | RET-fusion Non ... Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Disea... Head and Neck N... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Germ... Neoplasms, Nerv... | Pralsetinib Carboplatin Cisplatin Pemetrexed Pembrolizumab Gemcitabine Paclitaxel Nab-Paclitaxel | 18 Years - | Hoffmann-La Roche | |
| Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy | NCT02984761 | Lung Neoplasm | Stereotactic Ra... Anatomic Pulmon... | 18 Years - | VA Office of Research and Development | |
| Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease | NCT04630743 | Dyspnea Respiratory Ins... Neoplasms Pulmonary Disea... Lung Diseases Heart Failure Lung Diseases, ... Palliative Care Palliative Medi... Breathlessness | Cognitive and B... | 18 Years - | University of Cologne | |
| Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) | NCT04776447 | Lung Diseases Carcinoma, Non-... Stage IIIA Non-... Stage IIIB Non-... Respiratory Tra... Carcinoma Bronc... Thoracic Neopla... | Carboplatin Placlitaxel Atezolizumab | 18 Years - 75 Years | Fundación GECP | |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | NCT03134872 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Lung Diseases Respiratory Tra... Neoplasms by Si... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 Carboplatin Pemetrexed | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC | NCT05583188 | NSCLC | Aliya Pulsed El... Nivolumab plus ... Standard of car... Surgical Resect... | 18 Years - | Galvanize Therapeutics, Inc. | |
| A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer | NCT02259582 | Nonsquamous Non... | Pemetrexed Carboplatin demcizumab | 21 Years - | Mereo BioPharma | |
| Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC | NCT03389256 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-Small-Cell ... | Apatinib EGFR-TKI | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | NCT03134872 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Lung Diseases Respiratory Tra... Neoplasms by Si... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 Carboplatin Pemetrexed | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Efficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use Treatment | NCT05167500 | Metastatic Non ... | Lorlatinib | 18 Years - | Fundación GECP | |
| Lymphangioleiomyomatosis (LAM) Registry | NCT00005486 | Lung Diseases Lymphangiomyoma... | - 100 Years | National Heart, Lung, and Blood Institute (NHLBI) | ||
| Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) | NCT01999985 | Lung Cancer Non-small Cell ... | Dasatinib - 1A Afatinib - 1A Dasatinib - 1B Afatinib - 1B | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases | NCT05012254 | Non Small Cell ... Brain Metastase... Lung Cancer | Ipilimumab Nivolumab Carboplatin Cisplatin Paclitaxel Pemetrexed | 18 Years - | Fundación GECP | |
| Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) | NCT00250068 | Lung Diseases Cancer | Liposomal 9-Nit... | 18 Years - | University of New Mexico | |
| Clinical Utility for Ion Endoluminal System | NCT03893539 | Pulmonary Nodul... Lung Cancer Lung Diseases | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection | NCT03704870 | Lung Cancer Lung Diseases Lung Cancer, No... Surgery Lung Adenocarci... | Chest Xray No daily chest ... | 18 Years - | University Health Network, Toronto | |
| Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC | NCT04371796 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-small-cell ... | Sintilimab inje... | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer | NCT01039948 | Carcinoma, Non-... Lung Neoplasms Lung Cancer Respiratory Tra... | AV-299 + gefiti... Gefitinib | 18 Years - | AVEO Pharmaceuticals, Inc. | |
| Combination Paclitaxel, Carboplatin and Temozolomide | NCT00249964 | Lung Diseases Cancer | Combination Tre... Combination Tre... Combination Tre... Combination Tre... | 18 Years - | New Mexico Cancer Care Alliance | |
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer | NCT01574222 | Non-Small Cell ... | autologous dend... | 21 Years - | VA Office of Research and Development | |
| Pharmacology Study of Aerosolized Liposomal | NCT00250120 | Lung Diseases Cancer | L9NC: Liposomal... | 18 Years - | University of New Mexico | |
| The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging | NCT03849040 | Lung Diseases Lung Neoplasm | Endobronchial U... | 18 Years - | St. Joseph's Healthcare Hamilton | |
| Lymphangioleiomyomatosis (LAM) Registry | NCT00005486 | Lung Diseases Lymphangiomyoma... | - 100 Years | National Heart, Lung, and Blood Institute (NHLBI) | ||
| Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication | NCT02511600 | Lung Diseases Mesothelioma | Progel Sealant Talcum Powder Pain Questionna... | 18 Years - | M.D. Anderson Cancer Center | |
| Image - Navigated Resection of Lung Nodules | NCT04702165 | Lung Diseases | lung resection ... | 21 Years - | Navigation Sciences, Inc. | |
| A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection | NCT03083743 | Non-small-cell ... | Recombinant hum... Placebo | 18 Years - 75 Years | Shanghai Gebaide Biotechnology Co., Ltd. | |
| Effects of Transcutaneous Nerve Electrostimulation (TENS) of Acupuncture Points on Pulmonary Function and Dyspnea Symptoms in Patients With Pulmonary Nodules | NCT04051398 | Lung Diseases Dyspnea Acupuncture | transcutaneous ... | 18 Years - | Hospital Santa Marcelina | |
| Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC | NCT04371796 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-small-cell ... | Sintilimab inje... | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment | NCT03612804 | Smoking Reducti... Tobacco Use Tobacco Smoking Tomography Lung Diseases Lung Neoplasms | Unsigned note t... Proactive Telep... | - 80 Years | VA Office of Research and Development | |
| Pharmacology Study of Aerosolized Liposomal | NCT00250120 | Lung Diseases Cancer | L9NC: Liposomal... | 18 Years - | University of New Mexico | |
| Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers | NCT03598309 | Lung Diseases Lung Cancer, Pr... | Curcumin C3 com... Lovaza® Placebo | 55 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) | NCT02941601 | Locally Advance... Metastatic Squa... | Necitumumab Gemcitabine Carboplatin | 18 Years - | Eli Lilly and Company | |
| Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer) | NCT03053297 | Carcinoma, Non-... | Patient Reporte... | 18 Years - | AstraZeneca | |
| Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung) | NCT02134015 | Lung Cancer Non-small Cell ... | Patritumab Erlotinib Placebo | 20 Years - | Daiichi Sankyo | |
| Lung Cancer Risk and Early Detection in Firefighters | NCT04614129 | Lung Cancer Lung Diseases | Low Dose CT | 40 Years - 80 Years | Massachusetts General Hospital | |
| Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection | NCT03704870 | Lung Cancer Lung Diseases Lung Cancer, No... Surgery Lung Adenocarci... | Chest Xray No daily chest ... | 18 Years - | University Health Network, Toronto | |
| Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer | NCT05297734 | End of Life Cancer | Receive technol... Receive redesig... | 21 Years - | Stanford University | |
| Clinical Evaluation of ASP Health's Automated ROSE System for Bronchoscopic Applications | NCT05120050 | Lung Diseases Lung Cancer | ASP Health inst... | - | ASP Health | |
| Clinical Utility for Ion Endoluminal System | NCT03893539 | Pulmonary Nodul... Lung Cancer Lung Diseases | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy | NCT05941897 | Advanced or Met... | Ceralasertib Durvalumab | 18 Years - | AstraZeneca | |
| To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children Surgery | NCT05308771 | Abdominal Herni... Abdominal Wall ... Abdominal Neopl... Urogenital Dise... Urologic Neopla... Thoracic Diseas... Lung Diseases | VPC syringe | - 16 Years | Centre Hospitalier Universitaire de Tivoli | |
| Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment | NCT03612804 | Smoking Reducti... Tobacco Use Tobacco Smoking Tomography Lung Diseases Lung Neoplasms | Unsigned note t... Proactive Telep... | - 80 Years | VA Office of Research and Development | |
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma | NCT04725448 | Pulmonary Sarco... Non-small Cell ... Lung Diseases Thoracic Neopla... | Toripalimab Bevacizumab Nab-paclitaxel Carboplatin | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) | NCT02941601 | Locally Advance... Metastatic Squa... | Necitumumab Gemcitabine Carboplatin | 18 Years - | Eli Lilly and Company | |
| Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy | NCT04657120 | Pulmonary Embol... Embolism Embolism and Th... Vascular Diseas... Cardiovascular ... Lung Diseases Respiratory Tra... Cancer Diagnosis | YEARS algorithm CTPA | 18 Years - | University Hospital, Brest | |
| New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy | NCT04564157 | Non-Small Cell ... Adjuvant Chemot... | Carboplatin Paclitaxel Nivolumab | 18 Years - | Fundación GECP | |
| Ensuring Precision-Medicine Delivery for Veterans With Lung Cancer | NCT05795959 | Lung Cancer | Receive educati... | 18 Years - | Stanford University | |
| Retrospective Study of Carebot AI CXR Performance in Preclinical Practice | NCT05594485 | Artificial Inte... Lung Diseases Pneumothorax Pleural Effusio... Cardiomegaly Lung Cancer Pulmonary Edema Consolidation Pneumonia Atelectasis Hilar Calcifica... Fracture Rib | Carebot AI CXR | 18 Years - | Carebot s.r.o. | |
| Radiomics Multifactorial Biomarker for Pulmonary Nodules | NCT03872362 | Lung Neoplasms Carcinoma, Non-... Lung Diseases Neoplasms Pathology | radiomics | 18 Years - | Maastricht University | |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC | NCT04862780 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Nerv... EGFR T790M EGFR C797S EGFR L858R EGFR Gene Mutat... EGF-R Positive ... EGFR Exon 19 De... EGFR Mutation R... EGFR Activating... Protein Kinase ... Antineoplastic ... Thoracic Neopla... | BLU-945 osimertinib | 18 Years - | Blueprint Medicines Corporation | |
| Cough Capture as a Portal Into the Lung | NCT05854563 | Lung Diseases Lung Cancer Lung Diseases, ... Lung Diseases, ... Lung Inflammati... | Observational o... | 21 Years - 95 Years | Albert Einstein College of Medicine | |
| New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy | NCT04564157 | Non-Small Cell ... Adjuvant Chemot... | Carboplatin Paclitaxel Nivolumab | 18 Years - | Fundación GECP | |
| Lung Cancer Risk and Early Detection in Firefighters | NCT04614129 | Lung Cancer Lung Diseases | Low Dose CT | 40 Years - 80 Years | Massachusetts General Hospital | |
| The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial | NCT03402048 | Stage IV, NSCLC Lung Neoplasms Bronchial Neopl... Carcinoma, Bron... Lung Diseases Neoplasms Respiratory Tra... Respiratory Tra... Thoracic Neopla... | Carboplatin Gemcitabine Pemetrexed Docetaxel Vinorelbine | 70 Years - | University of Turin, Italy | |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | NCT02909452 | Neoplasms Neoplasms, Glan... Neoplasms by Hi... Bronchial Neopl... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Digestive Syste... Endocrine Gland... Carcinoma, Non-... Lung Diseases Breast Diseases Renal Neoplasm Solid Tumors | Entinostat Pembrolizumab | 18 Years - | Syndax Pharmaceuticals | |
| Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer | NCT03331588 | Lung Neoplasms Thoracic Surger... Carcinoma, Non-... Lung Diseases Carcinoma, Bron... Thoracic Neopla... | Subxiphoid unip... Intercostal uni... | 18 Years - 80 Years | Shanghai Pulmonary Hospital, Shanghai, China | |
| A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer | NCT01574222 | Non-Small Cell ... | autologous dend... | 21 Years - | VA Office of Research and Development | |
| Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients | NCT04512430 | Non Small Cell ... EGFR Gene Mutat... | Atezolizumab Bevacizumab Carboplatin Pemetrexed | 18 Years - | Fundación GECP | |
| 3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial | NCT05899270 | Lung Cancer Lung Diseases Tracheal Intuba... Throat Injury Bronchus; Injur... | 3D reconstructi... traditional met... | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| Modulation of Benzene Metabolism by Exposure to Environment | NCT00041860 | Lung Diseases Cancer | Controlled Expo... | - | National Institute of Environmental Health Sciences (NIEHS) | |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC | NCT05153408 | Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Nerv... EGFR C797S EGFR C797A EGFR L858R EGFR Exon 19 De... EGFR Gene Mutat... EGF-R Positive ... EGFR Mutation R... EGFR Activating... Thoracic Neopla... Antineoplastic ... Protein Kinase ... EGFR C797G EGFR C797X Non Small Cell ... | BLU-701 osimertinib carboplatin pemetrexed | 18 Years - | Blueprint Medicines Corporation | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| EBUS Score Validation for Malignancy | NCT02793713 | Lung Neoplasms Lung Diseases | Endobronchial U... | 18 Years - | McMaster University | |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | NCT03037385 | RET-altered Non... Medullary Thyro... RET-altered Pap... RET-altered Col... RET-altered Sol... Lung Neoplasm Carcinoma, Non-... Thyroid Disease... Thyroid Neoplas... Thyroid Cancer,... Carcinoma, Neur... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Endocrine Syste... Endocrine Gland... Head and Neck N... Adenocarcinoma,... Adenocarcinoma Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neuroendocrine ... Neuroectodermal... Neoplasms, Germ... Neoplasms, Nerv... Colonic Neoplas... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... | pralsetinib (BL... | 18 Years - | Hoffmann-La Roche | |
| A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer | NCT01039948 | Carcinoma, Non-... Lung Neoplasms Lung Cancer Respiratory Tra... | AV-299 + gefiti... Gefitinib | 18 Years - | AVEO Pharmaceuticals, Inc. | |
| The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging | NCT03849040 | Lung Diseases Lung Neoplasm | Endobronchial U... | 18 Years - | St. Joseph's Healthcare Hamilton | |
| Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease | NCT04630743 | Dyspnea Respiratory Ins... Neoplasms Pulmonary Disea... Lung Diseases Heart Failure Lung Diseases, ... Palliative Care Palliative Medi... Breathlessness | Cognitive and B... | 18 Years - | University of Cologne | |
| Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients | NCT03803787 | Radiation Pneum... | Inhaled budeson... | 18 Years - 75 Years | Instituto Nacional de Cancerologia de Mexico | |
| Lung Cancer Case Registry and Tissue Resource | NCT00250848 | Lung Cancer | - | University of New Mexico | ||
| Cough Capture as a Portal Into the Lung | NCT05854563 | Lung Diseases Lung Cancer Lung Diseases, ... Lung Diseases, ... Lung Inflammati... | Observational o... | 21 Years - 95 Years | Albert Einstein College of Medicine | |
| A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer | NCT01574222 | Non-Small Cell ... | autologous dend... | 21 Years - | VA Office of Research and Development | |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations | NCT05241873 | Lung Neoplasm M... Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... EGFR Exon 20 Mu... EGFR Exon 20 In... EGFR Activating... Antineoplastic ... Metastatic Lung... Brain Metastase... EGFR-mutated NS... EGFR Atypical M... | BLU-451 Carboplatin Pemetrexed | 18 Years - | Blueprint Medicines Corporation | |
| Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy | NCT02984761 | Lung Neoplasm | Stereotactic Ra... Anatomic Pulmon... | 18 Years - | VA Office of Research and Development | |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | NCT02897778 | Neoplasms Neoplasms, Glan... Neoplasms by Hi... Bronchial Neopl... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Digestive Syste... Endocrine Gland... Carcinoma, Non-... Lung Diseases Breast Neoplasm... Breast Diseases Renal Neoplasm Solid Tumors | Entinostat Placebo | 18 Years - | Syndax Pharmaceuticals | |
| Breath Analysis by Ion Mobility Spectrometry | NCT00632307 | Lung Diseases | 18 Years - 90 Years | Lung Clinic Hemer | ||
| Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC | NCT04133337 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-small-cell ... | Apatinib SHR-1210 | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
